Citations

Showing 10 of 108081 citations.

How to record high‐frequency oscillations in epilepsy: A practical guideline
Zijlmans, Maeike , Dümpelmann, Matthias , Stieglitz, Thomas , Barborică, Andrei , Heers, Marcel , Usui, Naotaka , Quyen, Michel Le Van , Barborica, Andrei , Worrell, Gregory A. , Ikeda, Akio , Dümpelmann, Matthias , Zijlmans, Maeike

Mayo Clinic

Epilepsia | June 16, 2017 | Volume: 58 | Issue: 8 | Pages: 1305-1315

10.1111/epi.13814 | PMID 28622421 Get It

Summary Objective Technology for localizing epileptogenic brain regions plays a central role in surgical planning. Recent improvements in acquisition and electrode technology have revealed that high‐frequency oscillations ( HFO s) within the 80–500 Hz frequency range provide the neurophysiologist with new information about the extent of the epileptogenic tissue in addition to ictal and interictal lower frequency events. Nevertheless, two decades after their discovery there remain questions about HFO s as biomarkers of epileptogenic brain and there use in clinical practice. Methods In this review, we provide practical, technical guidance for epileptologists and clinical researchers on recording, evaluation, and interpretation of ripples, fast ripples, and very high‐frequency oscillations. Results We emphasize the importance of low noise recording to minimize artifacts. HFO analysis, either visual or with automatic detection methods, of high fidelity recordings can still be challenging because of various artifacts including muscle, movement, and filtering. Magnetoencephalography and intracranial electroencephalography ( iEEG) recordings are subject to the same artifacts. Significance High‐frequency oscillations are promising new biomarkers in epilepsy. This review provides interested researchers and clinicians with a review of current state of the art of recording and identification and potential challenges to clinical translation.
Imaging Spectrum of Invasive Fungal and Fungal-like Infections
Orlowski, Hilary L.P. , McWilliams, Sebastian , Mellnick, Vincent M. , Lubner, Meghan G. , Pickhardt, Perry J. , Menias, Christine O. , Bhalla, Sanjeev , Mellnick, Vincent

Mayo Clinic

RadioGraphics | June 16, 2017 | Volume: 37 | Issue: 4 | Pages: 1119-1134

10.1148/rg.2017160110 | PMID 28622118 Get It

Waveform Window #39: Deep Brain Stimulator Artifact on EEG Recording
Aniles, Ejerzain

Mayo Clinic

The Neurodiagnostic Journal | June 16, 2017 | Volume: 57 | Issue: 2 | Pages: 165-167

10.1080/21646821.2017.1311747 | PMID 28622124 Get It

The health information national trends survey (HINTS): A resource for consumer engagement and health communication research
Hesse, Bradford W. , Greenberg, Alexandra J. , Peterson, Emily , Chou, Wen‐Ying Sylvia

Mayo Clinic

Information Services and Use | June 16, 2017 | Volume: 37 | Issue: 2 | Pages: 205-218

10.3233/isu-170830 Get It

The contemporary healthcare system can help improve health literacy outcomes in two ways: first, by nurturing the skills and motivations needed for patients to be actively engaged in their own health and healthcare decisions; and, second, by creating a prepared and proactive healthcare system that adapts to patients’ capacities and needs in efficacious ways. In 2001, the National Cancer Institute launched the Health Information National Trends Survey (HINTS) as a way for researchers and planners to understand how the public is interacting with a rapidly changing health information environment. Original iterations of the HINTS national probability sampling strategies took place on a biennial basis, but in subsequent years the protocol moved to a yearly administration. This yields a rich resource of cross-sectional, national surveillance data to evaluate for trends across and within vulnerable populations. Sixteen studies are presented from the published literature to illustrate how HINTS data were used to explore constructs of direct interest to health literacy researchers. Suggestions are given for how this ongoing public surveillance mechanism can be used: (a) to provide a sentinel view of how the public is interacting with information in the environment to address their health needs; (b) to generate research questions and hypotheses for further exploration using complementary methodologies; and (c) to explore the diffusion of new health communication channels within and between segments of the national population.
Restoration of Articular Geometry Using Current Graft Options for Large Glenoid Bone Defects in Anterior Shoulder Instability
Willemot, Laurent , Akbari-Shandiz, Mohsen , Zhao, Kristin D. , Verborgt, Olivier , Willemot, Laurent B, Sanchez-Sotelo, Joaquin, Zhao, Kristin, Sánchez‐Sotelo, Joaquín , Trentadue, Taylor P

Mayo Clinic

Arthroscopy | June 16, 2017 | Volume: 33 | Issue: 9 | Pages: 1661-1669

10.1016/j.arthro.2017.04.002 | PMID 28623079 Get It

Purpose The purpose of this cadaveric study was to compare standard and modified coracoid transfer procedures, bicortical and tricortical iliac crest autografts, and tibial plafond and glenoid allografts with respect to glenoid surface curvature restoration. Methods Computed tomography scans of 8 cadaveric shoulders were acquired in 9 conditions: (1) intact, (2) 25% width defect, (3) classic Latarjet, (4) modified congruent‐arc Latarjet, (5) tricortical iliac crest inner table, (6) outer table, (7) bicortical iliac crest, (8) distal tibia, and (9) glenoid allograft. Outcome measures included articular surface area, width, depth, axial and coronal radius of curvature, and subchondral articular step‐off, analyzed in bone and soft‐tissue window. Results Reconstruction of the articular surface area was optimal with the glenoid allograft (99.4%), classic Latarjet (97.4%), and iliac crest bicortical graft (93.2%). Depth was best restored by the congruent‐arc Latarjet (101.0%), tibial (98.9%), and glenoid (95.3%) allografts. Axial curvature was closely matched by the glenoid allograft (97.5%), classic Latarjet (108.7%), and iliac bicortical graft (91.2%). Coronal curvature was most accurately restored by the glenoid allograft (102.6%), the tibial allograft (115.0%), and the classic Latarjet (55.9%). The articular step‐off was smallest using the glenoid allograft. Conclusions Overall, glenoid allografts most accurately restored articular geometry. Alternative grafts provided restoration of some parameters but not others. Classic Latarjet performed well in axial and coronal curvature on average but exhibited large variability. Tibial allograft produced the poorest results in axial curvature, despite excellent coronal curvature reconstruction. The congruent‐arc Latarjet did not restore the axial curvature accurately and overcorrected coronal curvature. Graft geometry must be weighed against availability, morbidity, and the role of additional stabilizers. Clinical Relevance Accurate graft morphology may help prevent postoperative osteoarthritis. Grafts differ significantly regarding geometric parameters. The findings of this study will help surgeons select the most appropriate graft for glenoid reconstruction.
A consensus review on malignancy‐associated hemophagocytic lymphohistiocytosis in adults
Daver, Naval , McClain, Kenneth L. , Allen, Carl E. , Otrock, Zaher K. , Rojas‐Hernandez, Cristhiam M. , Blechacz, Boris, Wang, Sa , Minkov, Milen , Jordan, Michael B. , Rosée, Paul La , Kantarjian, Hagop M. , Parikh, Sameer A. , Daver, Naval , McClain, Kenneth L , Allen, Carl E , Kantarjian, Hagop

Mayo Clinic

Cancer | June 16, 2017 | Volume: 123 | Issue: 17 | Pages: 3229-3240

10.1002/cncr.30826 | PMID 28621800 Get It

Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of severe immune activation and dysregulation resulting in extreme and often life‐threatening inflammation. HLH has been well recognized in pediatric populations, and most current diagnostic and therapeutic guidelines are based on pediatric HLH. Recently there has been recognition of HLH in adults, especially secondary to immune deregulation by an underlying rheumatologic, infectious, or malignant condition. This review is focused on malignancy‐associated HLH (M‐HLH), in which possible mechanisms of pathogenesis include severe inflammation, persistent antigen stimulation by the tumor cells, and loss of immune homeostasis because of chemotherapy, hematopoietic stem cell transplantation, or infection. Previously considered rare, M‐HLH may occur in up to 1% of patients with hematologic malignancies. M‐HLH is often missed or diagnosed late in most published studies, and it has been associated with a poor median survival of less than 2 months. Identification of the clinical and laboratory features specific to M‐HLH in adults may allow early detection, consultation with HLH experts, and intervention. Improved management of adult M‐HLH with optimal combinations of T‐lympholytic and immunosuppressive agents and the incorporation of novel agents based on the pediatric experience hopefully will improve outcomes in adults with M‐HLH. Cancer 2017;123:3229‐40. © 2017 American Cancer Society.
Erratum: “Estimating organ doses from tube current modulated CT examinations using a generalized linear model” [Med. Phys. Vol 44 (4), 1500-1513 (2017)]
Bostani, Maryam, McMillan, Kyle, Lu, Peiyun, Cody, Dianna D. , Arbique, Gary, Greenberg, S. Bruce , DeMarco, John J., Cagnon, Chris H., Kim, Grace Hyun J. , McNitt‐Gray, Michael F.

Mayo Clinic

Medical Physics | June 16, 2017 | Volume: 44 | Issue: 7 | Pages: 3883-3883

10.1002/mp.12324 | PMID 28685929 Get It

2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
Springer, Bryan D. , Dasa, Vinod , George, Michael , Gewurz‐Singer, Ora, Giles, Jon T. , Johnson, Beverly , Mandl, Lisa A. , Mont, Michael A. , Sculco, Peter K. , Sporer, Scott M. , Stryker, Louis S., Turgunbaev, Marat, Brause, Barry D. , Gililland, Jeremy M. , Goodman, Mark A. , Hurley-Rosenblatt, Arlene, Kirou, Kyriakos A. , Losina, Elena , MacKenzie, Ronald, Russell, Linda , Sah, Alexander P. , Miller, Amy S., Singh, Jasvinder A. , Yates, Adolph J. , Losina, Elena , George, Michael , Losina, Elena , Singh, Jasvinder A , Goodman, Susan M. , Guyatt, Gordon , Abdel, Matthew P. , Lee, Steve C. , Chen, Antonia F. , Michaud, Kaleb D. , Mikuls, Ted R. , Losina, Elena , Giles, Jon T , Kirou, Kyriakos A

Mayo Clinic

Arthritis Care & Research | June 16, 2017 | Volume: 69 | Issue: 8 | Pages: 1111-1124

10.1002/acr.23274 | PMID 28620917 Get It

Objective This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence‐based guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid arthritis (RA), spondyloarthritis (SpA) including ankylosing spondylitis and psoriatic arthritis, juvenile idiopathic arthritis (JIA), or systemic lupus erythematosus (SLE) undergoing elective total hip (THA) or total knee arthroplasty (TKA). Methods A panel of rheumatologists, orthopedic surgeons specializing in hip and knee arthroplasty, and methodologists was convened to construct the key clinical questions to be answered in the guideline. A multi‐step systematic literature review was then conducted, from which evidence was synthesized for continuing versus withholding antirheumatic drug therapy and for optimal glucocorticoid management in the perioperative period. A Patient Panel was convened to determine patient values and preferences, and the Grading of Recommendations Assessment, Development and Evaluation methodology was used to rate the quality of evidence and the strength of recommendations, using a group consensus process through a convened Voting Panel of rheumatologists and orthopedic surgeons. The strength of the recommendation reflects the degree of certainty that benefits outweigh harms of the intervention, or vice versa, considering the quality of available evidence and the variability in patient values and preferences. Results The guideline addresses the perioperative use of antirheumatic drug therapy including traditional disease‐modifying antirheumatic drugs, biologic agents, tofacitinib, and glucocorticoids in adults with RA, SpA, JIA, or SLE who are undergoing elective THA or TKA. It provides recommendations regarding when to continue, when to withhold, and when to restart these medications, and the optimal perioperative dosing of glucocorticoids. The guideline includes 7 recommendations, all of which are conditional and based on low‐ or moderate‐quality evidence. Conclusion This guideline should help decision‐making by clinicians and patients regarding perioperative antirheumatic medication management at the time of elective THA or TKA. These conditional recommendations reflect the paucity of high‐quality direct randomized controlled trial data.
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
Springer, Bryan D. , Dasa, Vinod , George, Michael , Gewurz‐Singer, Ora, Giles, Jon T. , Johnson, Beverly , Mandl, Lisa A. , Mont, Michael A. , Sculco, Peter K. , Sporer, Scott M. , Stryker, Louis S., Turgunbaev, Marat, Brause, Barry D. , Gililland, Jeremy M. , Goodman, Mark A. , Hurley-Rosenblatt, Arlene, Kirou, Kyriakos A. , Losina, Elena , MacKenzie, Ronald, Russell, Linda , Sah, Alexander P. , Miller, Amy S., Singh, Jasvinder A. , Yates, Adolph J. , Losina, Elena , George, Michael , Losina, Elena , Singh, Jasvinder A , Goodman, Susan M. , Guyatt, Gordon , Abdel, Matthew P. , Lee, Steve C. , Chen, Antonia F. , Michaud, Kaleb D. , Mikuls, Ted R. , Losina, Elena , Giles, Jon T , Kirou, Kyriakos A

Mayo Clinic

Arthritis & Rheumatology | June 16, 2017 | Volume: 69 | Issue: 8 | Pages: 1538-1551

10.1002/art.40149 | PMID 28620948 Get It

ObjectiveThis collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence‐based guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid arthritis (RA), spondyloarthritis (SpA) including ankylosing spondylitis and psoriatic arthritis, juvenile idiopathic arthritis (JIA), or systemic lupus erythematosus (SLE) undergoing elective total hip (THA) or total knee arthroplasty (TKA).MethodsA panel of rheumatologists, orthopedic surgeons specializing in hip and knee arthroplasty, and methodologists was convened to construct the key clinical questions to be answered in the guideline. A multi‐step systematic literature review was then conducted, from which evidence was synthesized for continuing versus withholding antirheumatic drug therapy and for optimal glucocorticoid management in the perioperative period. A Patient Panel was convened to determine patient values and preferences, and the Grading of Recommendations Assessment, Development and Evaluation methodology was used to rate the quality of evidence and the strength of recommendations, using a group consensus process through a convened Voting Panel of rheumatologists and orthopedic surgeons. The strength of the recommendation reflects the degree of certainty that benefits outweigh harms of the intervention, or vice versa, considering the quality of available evidence and the variability in patient values and preferences.ResultsThe guideline addresses the perioperative use of antirheumatic drug therapy including traditional disease‐modifying antirheumatic drugs, biologic agents, tofacitinib, and glucocorticoids in adults with RA, SpA, JIA, or SLE who are undergoing elective THA or TKA. It provides recommendations regarding when to continue, when to withhold, and when to restart these medications, and the optimal perioperative dosing of glucocorticoids. The guideline includes 7 recommendations, all of which are conditional and based on low‐ or moderate‐quality evidence.ConclusionThis guideline should help decision‐making by clinicians and patients regarding perioperative antirheumatic medication management at the time of elective THA or TKA. These conditional recommendations reflect the paucity of high‐quality direct randomized controlled trial data.
Mitochondrial Integrity and Function in the Progression of Early Pressure Overload–Induced Left Ventricular Remodeling
Chaanine, Antoine H. , Bergen, Robert H., Klaus, Katherine A. , Guenzel, Adam J. , Hajjar, Roger J. , Redfield, Margaret M. , Klaus, Katherine, Nair, K. Sreekumaran

Mayo Clinic

Journal of the American Heart Association | June 16, 2017 | Volume: 6 | Issue: 6 | Pages: No page available

10.1161/jaha.117.005869 | PMID 28619984 Get It

Background Following pressure overload, compensatory concentric left ventricular remodeling ( CR ) variably transitions to eccentric remodeling ( ER ) and systolic dysfunction. Mechanisms responsible for this transition are incompletely understood. Here we leverage phenotypic variability in pressure overload–induced cardiac remodeling to test the hypothesis that altered mitochondrial homeostasis and calcium handling occur early in the transition from CR to ER , before overt systolic dysfunction. Methods and Results Sprague Dawley rats were subjected to ascending aortic banding, (n=68) or sham procedure (n=5). At 3 weeks post–ascending aortic banding, all rats showed CR (left ventricular volumes < sham). At 8 weeks post–ascending aortic banding, ejection fraction was increased or preserved but 3 geometric phenotypes were evident despite similar pressure overload severity: persistent CR , mild ER , and moderate ER with left ventricular volumes lower than, similar to, and higher than sham, respectively. Relative to sham, CR and mild ER phenotypes displayed increased phospholamban, S16 phosphorylation, reduced sodium‐calcium exchanger expression, and increased mitochondrial biogenesis/content and normal oxidative capacity, whereas moderate ER phenotype displayed decreased p‐phospholamban, S16, increased sodium‐calcium exchanger expression, similar degree of mitochondrial biogenesis/content, and impaired oxidative capacity with unique activation of mitochondrial autophagy and apoptosis markers ( BNIP 3 and Bax/Bcl‐2). Conclusions After pressure overload, mitochondrial biogenesis and function and calcium handling are enhanced in compensatory CR . The transition to mild ER is associated with decrease in mitochondrial biogenesis and content; however, the progression to moderate ER is associated with enhanced mitochondrial autophagy/apoptosis and impaired mitochondrial function and calcium handling, which precede the onset of overt systolic dysfunction.